MICHELLE ANDERSON: Open Payments
NPI 1013302496 · WILLOW GROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 38 payments from 11 companies in 2025. Trend: 2023 $519 · 2024 $258 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $193 |
| Ardelyx, Inc. | 3 | $168 |
| AKEBIA THERAPEUTICS INC | 5 | $105 |
| Calliditas Therapeutics US Inc. | 4 | $97 |
| Laborie Medical Technologies Corp. | 2 | $93 |
| Travere Therapeutics, Inc. | 5 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| COLOPLAST CORP | 1 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| CorMedix Inc. | 1 | $19 |
Products named: XPHOZAH 30 MG, Vafseo, TARPEYO, Optilume BPH Drug Coated Balloon Catheter, Fabhalta, Kerendia, Vanrafia, Titan.
Industry payments across PA — which companies pay providers there.
